| GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor | 5.41% (10/185) | 8.51 | 0.0 | 0.0 |
| GO:1901566 | organonitrogen compound biosynthetic process | 14.59% (27/185) | 3.55 | 0.0 | 0.0 |
| GO:0046394 | carboxylic acid biosynthetic process | 10.81% (20/185) | 4.37 | 0.0 | 0.0 |
| GO:0016053 | organic acid biosynthetic process | 10.81% (20/185) | 4.37 | 0.0 | 0.0 |
| GO:0003958 | NADPH-hemoprotein reductase activity | 4.32% (8/185) | 9.02 | 0.0 | 0.0 |
| GO:0044283 | small molecule biosynthetic process | 11.89% (22/185) | 3.95 | 0.0 | 0.0 |
| GO:0044281 | small molecule metabolic process | 17.84% (33/185) | 2.91 | 0.0 | 0.0 |
| GO:0044272 | sulfur compound biosynthetic process | 7.03% (13/185) | 5.42 | 0.0 | 0.0 |
| GO:0006082 | organic acid metabolic process | 13.51% (25/185) | 3.21 | 0.0 | 0.0 |
| GO:0043436 | oxoacid metabolic process | 13.51% (25/185) | 3.21 | 0.0 | 0.0 |
| GO:0019752 | carboxylic acid metabolic process | 13.51% (25/185) | 3.21 | 0.0 | 0.0 |
| GO:0003987 | acetate-CoA ligase activity | 3.24% (6/185) | 9.25 | 0.0 | 0.0 |
| GO:0006520 | amino acid metabolic process | 10.27% (19/185) | 3.74 | 0.0 | 0.0 |
| GO:0010181 | FMN binding | 4.86% (9/185) | 6.47 | 0.0 | 0.0 |
| GO:0003824 | catalytic activity | 42.7% (79/185) | 1.24 | 0.0 | 0.0 |
| GO:0006085 | acetyl-CoA biosynthetic process | 4.32% (8/185) | 6.71 | 0.0 | 0.0 |
| GO:0035384 | thioester biosynthetic process | 4.32% (8/185) | 6.66 | 0.0 | 0.0 |
| GO:0071616 | acyl-CoA biosynthetic process | 4.32% (8/185) | 6.66 | 0.0 | 0.0 |
| GO:0016491 | oxidoreductase activity | 15.68% (29/185) | 2.49 | 0.0 | 0.0 |
| GO:0030865 | cortical cytoskeleton organization | 3.78% (7/185) | 7.22 | 0.0 | 0.0 |
| GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 5.41% (10/185) | 5.4 | 0.0 | 0.0 |
| GO:0050660 | flavin adenine dinucleotide binding | 6.49% (12/185) | 4.62 | 0.0 | 0.0 |
| GO:0006790 | sulfur compound metabolic process | 7.03% (13/185) | 4.34 | 0.0 | 0.0 |
| GO:0006084 | acetyl-CoA metabolic process | 4.32% (8/185) | 6.3 | 0.0 | 0.0 |
| GO:0010089 | xylem development | 2.16% (4/185) | 10.86 | 0.0 | 0.0 |
| GO:0033866 | nucleoside bisphosphate biosynthetic process | 4.32% (8/185) | 6.1 | 0.0 | 0.0 |
| GO:0034030 | ribonucleoside bisphosphate biosynthetic process | 4.32% (8/185) | 6.1 | 0.0 | 0.0 |
| GO:0034033 | purine nucleoside bisphosphate biosynthetic process | 4.32% (8/185) | 6.1 | 0.0 | 0.0 |
| GO:0110165 | cellular anatomical entity | 40.0% (74/185) | 1.18 | 0.0 | 0.0 |
| GO:0009073 | aromatic amino acid family biosynthetic process | 4.32% (8/185) | 5.96 | 0.0 | 0.0 |
| GO:0044249 | cellular biosynthetic process | 15.14% (28/185) | 2.33 | 0.0 | 0.0 |
| GO:0005829 | cytosol | 10.81% (20/185) | 2.93 | 0.0 | 0.0 |
| GO:0035383 | thioester metabolic process | 4.32% (8/185) | 5.63 | 0.0 | 0.0 |
| GO:0006637 | acyl-CoA metabolic process | 4.32% (8/185) | 5.63 | 0.0 | 0.0 |
| GO:1901576 | organic substance biosynthetic process | 15.14% (28/185) | 2.21 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 50.81% (94/185) | 0.87 | 0.0 | 0.0 |
| GO:1901564 | organonitrogen compound metabolic process | 24.32% (45/185) | 1.55 | 0.0 | 0.0 |
| GO:0009058 | biosynthetic process | 15.14% (28/185) | 2.13 | 0.0 | 0.0 |
| GO:0019438 | aromatic compound biosynthetic process | 9.19% (17/185) | 2.99 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 40.54% (75/185) | 1.02 | 0.0 | 0.0 |
| GO:0034032 | purine nucleoside bisphosphate metabolic process | 4.32% (8/185) | 5.07 | 0.0 | 0.0 |
| GO:0033875 | ribonucleoside bisphosphate metabolic process | 4.32% (8/185) | 5.07 | 0.0 | 0.0 |
| GO:0033865 | nucleoside bisphosphate metabolic process | 4.32% (8/185) | 5.07 | 0.0 | 0.0 |
| GO:0009072 | aromatic amino acid metabolic process | 4.32% (8/185) | 5.07 | 0.0 | 0.0 |
| GO:0043622 | cortical microtubule organization | 2.7% (5/185) | 7.39 | 0.0 | 0.0 |
| GO:0046417 | chorismate metabolic process | 2.7% (5/185) | 7.34 | 0.0 | 0.0 |
| GO:0072522 | purine-containing compound biosynthetic process | 4.86% (9/185) | 4.55 | 0.0 | 0.0 |
| GO:0010087 | phloem or xylem histogenesis | 2.16% (4/185) | 8.62 | 0.0 | 0.0 |
| GO:1901362 | organic cyclic compound biosynthetic process | 9.19% (17/185) | 2.84 | 0.0 | 0.0 |
| GO:0055028 | cortical microtubule | 2.7% (5/185) | 7.09 | 0.0 | 0.0 |
| GO:0016405 | CoA-ligase activity | 3.78% (7/185) | 5.41 | 0.0 | 0.0 |
| GO:0006081 | cellular aldehyde metabolic process | 3.78% (7/185) | 5.42 | 0.0 | 0.0 |
| GO:0010005 | cortical microtubule, transverse to long axis | 2.16% (4/185) | 8.5 | 0.0 | 0.0 |
| GO:0009152 | purine ribonucleotide biosynthetic process | 4.32% (8/185) | 4.86 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 37.3% (69/185) | 1.02 | 0.0 | 0.0 |
| GO:0016878 | acid-thiol ligase activity | 3.24% (6/185) | 5.86 | 0.0 | 0.0 |
| GO:0042085 | 5-methyltetrahydropteroyltri-L-glutamate-dependent methyltransferase activity | 2.16% (4/185) | 8.08 | 0.0 | 0.0 |
| GO:0003871 | 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity | 2.16% (4/185) | 8.08 | 0.0 | 0.0 |
| GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity | 2.7% (5/185) | 6.71 | 0.0 | 0.0 |
| GO:0004029 | aldehyde dehydrogenase (NAD+) activity | 2.7% (5/185) | 6.71 | 0.0 | 0.0 |
| GO:0009086 | methionine biosynthetic process | 2.7% (5/185) | 6.67 | 0.0 | 0.0 |
| GO:0006555 | methionine metabolic process | 2.7% (5/185) | 6.55 | 0.0 | 0.0 |
| GO:0008652 | amino acid biosynthetic process | 4.86% (9/185) | 4.13 | 0.0 | 0.0 |
| GO:0006164 | purine nucleotide biosynthetic process | 4.32% (8/185) | 4.49 | 0.0 | 0.0 |
| GO:0009260 | ribonucleotide biosynthetic process | 4.32% (8/185) | 4.39 | 0.0 | 0.0 |
| GO:1901605 | alpha-amino acid metabolic process | 5.41% (10/185) | 3.72 | 0.0 | 0.0 |
| GO:0031122 | cytoplasmic microtubule organization | 2.7% (5/185) | 6.28 | 0.0 | 0.0 |
| GO:0046390 | ribose phosphate biosynthetic process | 4.32% (8/185) | 4.34 | 0.0 | 0.0 |
| GO:0008152 | metabolic process | 32.97% (61/185) | 1.04 | 0.0 | 0.0 |
| GO:0008172 | S-methyltransferase activity | 2.16% (4/185) | 7.38 | 0.0 | 0.0 |
| GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3.78% (7/185) | 4.71 | 0.0 | 0.0 |
| GO:0005881 | cytoplasmic microtubule | 2.7% (5/185) | 6.07 | 0.0 | 0.0 |
| GO:0044237 | cellular metabolic process | 26.49% (49/185) | 1.18 | 0.0 | 0.0 |
| GO:1901607 | alpha-amino acid biosynthetic process | 4.32% (8/185) | 4.07 | 0.0 | 0.0 |
| GO:0072521 | purine-containing compound metabolic process | 5.41% (10/185) | 3.37 | 0.0 | 1e-06 |
| GO:1901293 | nucleoside phosphate biosynthetic process | 4.32% (8/185) | 3.94 | 0.0 | 1e-06 |
| GO:0009165 | nucleotide biosynthetic process | 4.32% (8/185) | 3.94 | 0.0 | 1e-06 |
| GO:0006807 | nitrogen compound metabolic process | 26.49% (49/185) | 1.13 | 0.0 | 1e-06 |
| GO:0004106 | chorismate mutase activity | 1.62% (3/185) | 8.44 | 0.0 | 1e-06 |
| GO:0000097 | sulfur amino acid biosynthetic process | 2.7% (5/185) | 5.55 | 0.0 | 1e-06 |
| GO:0000096 | sulfur amino acid metabolic process | 2.7% (5/185) | 5.43 | 0.0 | 1e-06 |
| GO:0003674 | molecular_function | 54.05% (100/185) | 0.61 | 0.0 | 1e-06 |
| GO:0071704 | organic substance metabolic process | 30.27% (56/185) | 0.99 | 0.0 | 2e-06 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 4.86% (9/185) | 3.41 | 0.0 | 2e-06 |
| GO:0007010 | cytoskeleton organization | 4.32% (8/185) | 3.66 | 0.0 | 2e-06 |
| GO:0003849 | 3-deoxy-7-phosphoheptulonate synthase activity | 1.62% (3/185) | 7.86 | 0.0 | 2e-06 |
| GO:0043648 | dicarboxylic acid metabolic process | 3.24% (6/185) | 4.45 | 0.0 | 3e-06 |
| GO:0009067 | aspartate family amino acid biosynthetic process | 2.7% (5/185) | 5.11 | 0.0 | 3e-06 |
| GO:0006163 | purine nucleotide metabolic process | 4.86% (9/185) | 3.31 | 0.0 | 3e-06 |
| GO:0009150 | purine ribonucleotide metabolic process | 4.32% (8/185) | 3.52 | 1e-06 | 5e-06 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 5.41% (10/185) | 2.99 | 1e-06 | 5e-06 |
| GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 2.7% (5/185) | 4.88 | 1e-06 | 7e-06 |
| GO:0008378 | galactosyltransferase activity | 2.16% (4/185) | 5.69 | 1e-06 | 9e-06 |
| GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity | 1.08% (2/185) | 10.08 | 1e-06 | 1e-05 |
| GO:0009066 | aspartate family amino acid metabolic process | 2.7% (5/185) | 4.76 | 1e-06 | 1e-05 |
| GO:0098754 | detoxification | 2.16% (4/185) | 5.6 | 2e-06 | 1.1e-05 |
| GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.7% (5/185) | 4.71 | 2e-06 | 1.1e-05 |
| GO:0009117 | nucleotide metabolic process | 4.86% (9/185) | 3.06 | 2e-06 | 1.2e-05 |
| GO:0009259 | ribonucleotide metabolic process | 4.32% (8/185) | 3.31 | 2e-06 | 1.2e-05 |
| GO:0006753 | nucleoside phosphate metabolic process | 4.86% (9/185) | 3.05 | 2e-06 | 1.3e-05 |
| GO:0019427 | acetyl-CoA biosynthetic process from acetate | 1.08% (2/185) | 9.86 | 2e-06 | 1.3e-05 |
| GO:0006083 | acetate metabolic process | 1.08% (2/185) | 9.86 | 2e-06 | 1.3e-05 |
| GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 2.7% (5/185) | 4.65 | 2e-06 | 1.3e-05 |
| GO:0019693 | ribose phosphate metabolic process | 4.32% (8/185) | 3.26 | 3e-06 | 1.6e-05 |
| GO:0043604 | amide biosynthetic process | 4.32% (8/185) | 3.2 | 3e-06 | 2e-05 |
| GO:0043603 | amide metabolic process | 4.86% (9/185) | 2.95 | 3e-06 | 2e-05 |
| GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.7% (5/185) | 4.45 | 4e-06 | 2.4e-05 |
| GO:0035999 | tetrahydrofolate interconversion | 1.62% (3/185) | 6.64 | 4e-06 | 2.5e-05 |
| GO:0016208 | AMP binding | 1.08% (2/185) | 9.34 | 4e-06 | 2.5e-05 |
| GO:0003866 | 3-phosphoshikimate 1-carboxyvinyltransferase activity | 1.08% (2/185) | 9.08 | 6e-06 | 3.7e-05 |
| GO:0097435 | supramolecular fiber organization | 3.24% (6/185) | 3.77 | 6e-06 | 3.7e-05 |
| GO:0009888 | tissue development | 2.16% (4/185) | 5.12 | 6e-06 | 3.7e-05 |
| GO:0000139 | Golgi membrane | 2.7% (5/185) | 4.26 | 8e-06 | 4.5e-05 |
| GO:0006730 | one-carbon metabolic process | 1.62% (3/185) | 6.04 | 1.5e-05 | 8.4e-05 |
| GO:0006996 | organelle organization | 6.49% (12/185) | 2.2 | 1.5e-05 | 8.7e-05 |
| GO:0046653 | tetrahydrofolate metabolic process | 1.62% (3/185) | 6.0 | 1.6e-05 | 8.9e-05 |
| GO:0090407 | organophosphate biosynthetic process | 4.32% (8/185) | 2.83 | 2.1e-05 | 0.000118 |
| GO:0019901 | protein kinase binding | 1.62% (3/185) | 5.84 | 2.2e-05 | 0.000122 |
| GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H | 1.08% (2/185) | 8.14 | 2.4e-05 | 0.00013 |
| GO:0044238 | primary metabolic process | 25.95% (48/185) | 0.85 | 2.7e-05 | 0.000146 |
| GO:0005874 | microtubule | 2.7% (5/185) | 3.86 | 2.9e-05 | 0.000154 |
| GO:0009069 | serine family amino acid metabolic process | 2.16% (4/185) | 4.56 | 2.9e-05 | 0.000155 |
| GO:0006725 | cellular aromatic compound metabolic process | 12.97% (24/185) | 1.33 | 3.2e-05 | 0.000171 |
| GO:0051213 | dioxygenase activity | 2.7% (5/185) | 3.8 | 3.5e-05 | 0.000184 |
| GO:0071949 | FAD binding | 2.16% (4/185) | 4.48 | 3.6e-05 | 0.000188 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 4.86% (9/185) | 2.51 | 3.7e-05 | 0.000189 |
| GO:0043231 | intracellular membrane-bounded organelle | 15.68% (29/185) | 1.16 | 4.1e-05 | 0.000208 |
| GO:0099512 | supramolecular fiber | 2.7% (5/185) | 3.73 | 4.4e-05 | 0.000217 |
| GO:0099081 | supramolecular polymer | 2.7% (5/185) | 3.73 | 4.4e-05 | 0.000217 |
| GO:1901135 | carbohydrate derivative metabolic process | 4.86% (9/185) | 2.47 | 4.3e-05 | 0.000218 |
| GO:0099513 | polymeric cytoskeletal fiber | 2.7% (5/185) | 3.73 | 4.3e-05 | 0.000219 |
| GO:0043227 | membrane-bounded organelle | 15.68% (29/185) | 1.15 | 4.7e-05 | 0.000227 |
| GO:0004765 | shikimate kinase activity | 1.08% (2/185) | 7.67 | 4.6e-05 | 0.000228 |
| GO:1901360 | organic cyclic compound metabolic process | 12.97% (24/185) | 1.29 | 5.1e-05 | 0.000247 |
| GO:0006564 | L-serine biosynthetic process | 1.08% (2/185) | 7.42 | 6.6e-05 | 0.000316 |
| GO:0043413 | macromolecule glycosylation | 2.7% (5/185) | 3.59 | 7e-05 | 0.000327 |
| GO:0006486 | protein glycosylation | 2.7% (5/185) | 3.59 | 7e-05 | 0.000327 |
| GO:0003878 | ATP citrate synthase activity | 1.08% (2/185) | 7.38 | 6.9e-05 | 0.000331 |
| GO:0006563 | L-serine metabolic process | 1.62% (3/185) | 5.21 | 8.2e-05 | 0.000383 |
| GO:0006497 | protein lipidation | 2.16% (4/185) | 4.15 | 8.7e-05 | 0.000404 |
| GO:0032956 | regulation of actin cytoskeleton organization | 1.62% (3/185) | 5.16 | 9e-05 | 0.000412 |
| GO:0032970 | regulation of actin filament-based process | 1.62% (3/185) | 5.15 | 9.3e-05 | 0.000423 |
| GO:0006760 | folic acid-containing compound metabolic process | 1.62% (3/185) | 5.14 | 9.5e-05 | 0.000426 |
| GO:0070085 | glycosylation | 2.7% (5/185) | 3.5 | 9.4e-05 | 0.000426 |
| GO:0042995 | cell projection | 1.08% (2/185) | 7.11 | 0.000101 | 0.000452 |
| GO:0042558 | pteridine-containing compound metabolic process | 1.62% (3/185) | 5.07 | 0.000109 | 0.000486 |
| GO:0005737 | cytoplasm | 9.19% (17/185) | 1.51 | 0.000116 | 0.000514 |
| GO:0019900 | kinase binding | 1.62% (3/185) | 5.02 | 0.00012 | 0.000521 |
| GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding | 1.08% (2/185) | 6.99 | 0.000119 | 0.000522 |
| GO:0000257 | nitrilase activity | 1.08% (2/185) | 6.91 | 0.000133 | 0.000566 |
| GO:0018822 | nitrile hydratase activity | 1.08% (2/185) | 6.91 | 0.000133 | 0.000566 |
| GO:0016815 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles | 1.08% (2/185) | 6.91 | 0.000133 | 0.000566 |
| GO:0051410 | detoxification of nitrogen compound | 1.08% (2/185) | 6.91 | 0.000133 | 0.000566 |
| GO:0000226 | microtubule cytoskeleton organization | 2.7% (5/185) | 3.38 | 0.000135 | 0.00057 |
| GO:0000719 | photoreactive repair | 1.08% (2/185) | 6.69 | 0.000182 | 0.000756 |
| GO:0006290 | pyrimidine dimer repair | 1.08% (2/185) | 6.69 | 0.000182 | 0.000756 |
| GO:0008360 | regulation of cell shape | 1.08% (2/185) | 6.56 | 0.000218 | 0.000902 |
| GO:0016740 | transferase activity | 15.68% (29/185) | 1.02 | 0.000228 | 0.000937 |
| GO:0018130 | heterocycle biosynthetic process | 4.86% (9/185) | 2.15 | 0.000237 | 0.000957 |
| GO:0043226 | organelle | 16.22% (30/185) | 0.99 | 0.000236 | 0.000957 |
| GO:0043229 | intracellular organelle | 16.22% (30/185) | 0.99 | 0.000236 | 0.000961 |
| GO:0051493 | regulation of cytoskeleton organization | 1.62% (3/185) | 4.67 | 0.000245 | 0.00098 |
| GO:0016874 | ligase activity | 3.78% (7/185) | 2.53 | 0.000247 | 0.000982 |
| GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 2.7% (5/185) | 3.17 | 0.000264 | 0.001044 |
| GO:0009423 | chorismate biosynthetic process | 1.08% (2/185) | 6.38 | 0.000279 | 0.00109 |
| GO:0034045 | phagophore assembly site membrane | 1.08% (2/185) | 6.38 | 0.000279 | 0.00109 |
| GO:0032266 | phosphatidylinositol-3-phosphate binding | 1.08% (2/185) | 6.34 | 0.000293 | 0.001139 |
| GO:0019637 | organophosphate metabolic process | 4.86% (9/185) | 2.1 | 0.000302 | 0.001161 |
| GO:0043167 | ion binding | 18.92% (35/185) | 0.88 | 0.000302 | 0.001165 |
| GO:0009071 | serine family amino acid catabolic process | 1.08% (2/185) | 6.26 | 0.000331 | 0.001263 |
| GO:0009070 | serine family amino acid biosynthetic process | 1.62% (3/185) | 4.39 | 0.000433 | 0.001644 |
| GO:0099080 | supramolecular complex | 2.7% (5/185) | 3.0 | 0.000457 | 0.001714 |
| GO:0016043 | cellular component organization | 7.57% (14/185) | 1.52 | 0.000457 | 0.001723 |
| GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1.08% (2/185) | 5.91 | 0.000533 | 0.001988 |
| GO:0006575 | cellular modified amino acid metabolic process | 1.62% (3/185) | 4.26 | 0.000559 | 0.002074 |
| GO:0004024 | alcohol dehydrogenase activity, zinc-dependent | 1.08% (2/185) | 5.83 | 0.000594 | 0.002176 |
| GO:0051903 | S-(hydroxymethyl)glutathione dehydrogenase activity | 1.08% (2/185) | 5.83 | 0.000594 | 0.002176 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 5.41% (10/185) | 1.83 | 0.0006 | 0.002186 |
| GO:0003904 | deoxyribodipyrimidine photo-lyase activity | 1.08% (2/185) | 5.77 | 0.000646 | 0.00233 |
| GO:0003913 | DNA photolyase activity | 1.08% (2/185) | 5.77 | 0.000646 | 0.00233 |
| GO:0046294 | formaldehyde catabolic process | 1.08% (2/185) | 5.75 | 0.000668 | 0.002356 |
| GO:0022604 | regulation of cell morphogenesis | 1.08% (2/185) | 5.75 | 0.000668 | 0.002356 |
| GO:0110095 | cellular detoxification of aldehyde | 1.08% (2/185) | 5.75 | 0.000668 | 0.002356 |
| GO:0046292 | formaldehyde metabolic process | 1.08% (2/185) | 5.75 | 0.000668 | 0.002356 |
| GO:0044282 | small molecule catabolic process | 2.7% (5/185) | 2.87 | 0.000682 | 0.002392 |
| GO:0034497 | protein localization to phagophore assembly site | 1.08% (2/185) | 5.68 | 0.000735 | 0.002566 |
| GO:0007163 | establishment or maintenance of cell polarity | 1.08% (2/185) | 5.67 | 0.000747 | 0.002592 |
| GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity | 1.08% (2/185) | 5.56 | 0.000867 | 0.002977 |
| GO:0004022 | alcohol dehydrogenase (NAD+) activity | 1.08% (2/185) | 5.56 | 0.000867 | 0.002977 |
| GO:0007017 | microtubule-based process | 2.7% (5/185) | 2.78 | 0.000882 | 0.003014 |
| GO:0050793 | regulation of developmental process | 1.62% (3/185) | 4.02 | 0.000903 | 0.003067 |
| GO:0046912 | acyltransferase activity, acyl groups converted into alkyl on transfer | 1.08% (2/185) | 5.49 | 0.000956 | 0.003231 |
| GO:0016741 | transferase activity, transferring one-carbon groups | 3.24% (6/185) | 2.42 | 0.001022 | 0.003436 |
| GO:0019707 | protein-cysteine S-acyltransferase activity | 1.08% (2/185) | 5.41 | 0.001063 | 0.003502 |
| GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 1.08% (2/185) | 5.41 | 0.001063 | 0.003502 |
| GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 1.08% (2/185) | 5.41 | 0.001063 | 0.003502 |
| GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 1.08% (2/185) | 5.41 | 0.001063 | 0.003502 |
| GO:0044804 | nucleophagy | 1.08% (2/185) | 5.37 | 0.001119 | 0.003667 |
| GO:0009611 | response to wounding | 1.08% (2/185) | 5.36 | 0.001133 | 0.003694 |
| GO:0018198 | peptidyl-cysteine modification | 1.08% (2/185) | 5.35 | 0.001147 | 0.003722 |
| GO:0048856 | anatomical structure development | 2.16% (4/185) | 3.15 | 0.001168 | 0.003773 |
| GO:0022603 | regulation of anatomical structure morphogenesis | 1.08% (2/185) | 5.33 | 0.00119 | 0.003824 |
| GO:0005794 | Golgi apparatus | 2.7% (5/185) | 2.68 | 0.001201 | 0.00384 |
| GO:0006544 | glycine metabolic process | 1.08% (2/185) | 5.28 | 0.001264 | 0.00402 |
| GO:0071840 | cellular component organization or biogenesis | 7.57% (14/185) | 1.36 | 0.001293 | 0.004093 |
| GO:0007264 | small GTPase mediated signal transduction | 1.08% (2/185) | 5.16 | 0.001497 | 0.004716 |
| GO:2000022 | regulation of jasmonic acid mediated signaling pathway | 1.08% (2/185) | 5.12 | 0.001579 | 0.004951 |
| GO:1990748 | cellular detoxification | 1.08% (2/185) | 5.0 | 0.001856 | 0.00579 |
| GO:1901606 | alpha-amino acid catabolic process | 1.62% (3/185) | 3.65 | 0.001877 | 0.005828 |
| GO:0046185 | aldehyde catabolic process | 1.08% (2/185) | 4.91 | 0.002096 | 0.006477 |
| GO:0000422 | autophagy of mitochondrion | 1.08% (2/185) | 4.9 | 0.002134 | 0.006564 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 1.08% (2/185) | 4.87 | 0.002212 | 0.00677 |
| GO:0009063 | amino acid catabolic process | 1.62% (3/185) | 3.55 | 0.002277 | 0.006905 |
| GO:0016236 | macroautophagy | 1.08% (2/185) | 4.85 | 0.002271 | 0.006918 |
| GO:0006633 | fatty acid biosynthetic process | 1.62% (3/185) | 3.53 | 0.002355 | 0.007108 |
| GO:0016417 | S-acyltransferase activity | 1.08% (2/185) | 4.81 | 0.002411 | 0.007244 |
| GO:0018345 | protein palmitoylation | 1.08% (2/185) | 4.76 | 0.002576 | 0.007705 |
| GO:0043168 | anion binding | 13.51% (25/185) | 0.87 | 0.002611 | 0.007774 |
| GO:0022411 | cellular component disassembly | 1.62% (3/185) | 3.43 | 0.002866 | 0.008492 |
| GO:0044248 | cellular catabolic process | 3.78% (7/185) | 1.89 | 0.003145 | 0.009277 |
| GO:0050684 | regulation of mRNA processing | 1.08% (2/185) | 4.6 | 0.003196 | 0.009385 |
| GO:0043650 | dicarboxylic acid biosynthetic process | 1.08% (2/185) | 4.59 | 0.003242 | 0.009479 |
| GO:0035556 | intracellular signal transduction | 2.7% (5/185) | 2.33 | 0.003456 | 0.010057 |
| GO:0016866 | intramolecular transferase activity | 1.62% (3/185) | 3.3 | 0.003725 | 0.010793 |
| GO:0019899 | enzyme binding | 2.16% (4/185) | 2.65 | 0.004009 | 0.011563 |
| GO:0043484 | regulation of RNA splicing | 1.08% (2/185) | 4.42 | 0.004084 | 0.011728 |
| GO:0072330 | monocarboxylic acid biosynthetic process | 1.62% (3/185) | 3.24 | 0.004124 | 0.01179 |
| GO:0019898 | extrinsic component of membrane | 1.08% (2/185) | 4.39 | 0.004216 | 0.011947 |
| GO:0005856 | cytoskeleton | 1.62% (3/185) | 3.23 | 0.004213 | 0.011993 |
| GO:0071008 | U2-type post-mRNA release spliceosomal complex | 0.54% (1/185) | 7.86 | 0.004301 | 0.012138 |
| GO:0008168 | methyltransferase activity | 2.7% (5/185) | 2.21 | 0.004861 | 0.013659 |
| GO:0000287 | magnesium ion binding | 1.62% (3/185) | 3.12 | 0.005224 | 0.014615 |
| GO:0032502 | developmental process | 2.16% (4/185) | 2.54 | 0.005286 | 0.014661 |
| GO:0032787 | monocarboxylic acid metabolic process | 2.7% (5/185) | 2.18 | 0.005264 | 0.014661 |
| GO:0016409 | palmitoyltransferase activity | 1.08% (2/185) | 4.2 | 0.005455 | 0.015066 |
| GO:0033043 | regulation of organelle organization | 1.62% (3/185) | 3.09 | 0.005564 | 0.015302 |
| GO:0043169 | cation binding | 7.03% (13/185) | 1.16 | 0.005954 | 0.016237 |
| GO:1901363 | heterocyclic compound binding | 12.97% (24/185) | 0.8 | 0.00593 | 0.01624 |
| GO:0008270 | zinc ion binding | 3.78% (7/185) | 1.72 | 0.005982 | 0.016243 |
| GO:0031347 | regulation of defense response | 1.08% (2/185) | 4.11 | 0.006193 | 0.016748 |
| GO:0140034 | methylation-dependent protein binding | 0.54% (1/185) | 7.27 | 0.006445 | 0.017214 |
| GO:0035064 | methylated histone binding | 0.54% (1/185) | 7.27 | 0.006445 | 0.017214 |
| GO:0036094 | small molecule binding | 12.97% (24/185) | 0.79 | 0.006426 | 0.017305 |
| GO:1903008 | organelle disassembly | 1.08% (2/185) | 4.05 | 0.006676 | 0.017758 |
| GO:1901879 | regulation of protein depolymerization | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0051693 | actin filament capping | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0051016 | barbed-end actin filament capping | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:1901880 | negative regulation of protein depolymerization | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0043242 | negative regulation of protein-containing complex disassembly | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0030835 | negative regulation of actin filament depolymerization | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0030834 | regulation of actin filament depolymerization | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0008290 | F-actin capping protein complex | 0.54% (1/185) | 7.08 | 0.007363 | 0.018962 |
| GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 1.08% (2/185) | 3.96 | 0.007553 | 0.019375 |
| GO:0008104 | protein localization | 3.24% (6/185) | 1.8 | 0.008209 | 0.020893 |
| GO:0006099 | tricarboxylic acid cycle | 1.08% (2/185) | 3.9 | 0.008189 | 0.020923 |
| GO:0070727 | cellular macromolecule localization | 3.24% (6/185) | 1.79 | 0.008297 | 0.021034 |
| GO:1901265 | nucleoside phosphate binding | 12.43% (23/185) | 0.77 | 0.0084 | 0.021048 |
| GO:0000166 | nucleotide binding | 12.43% (23/185) | 0.77 | 0.0084 | 0.021048 |
| GO:0033036 | macromolecule localization | 3.24% (6/185) | 1.79 | 0.008372 | 0.021142 |
| GO:0016710 | trans-cinnamate 4-monooxygenase activity | 0.54% (1/185) | 6.86 | 0.008584 | 0.021346 |
| GO:0043069 | negative regulation of programmed cell death | 0.54% (1/185) | 6.86 | 0.008584 | 0.021346 |
| GO:0046621 | negative regulation of organ growth | 0.54% (1/185) | 6.81 | 0.00889 | 0.02202 |
| GO:0098588 | bounding membrane of organelle | 2.7% (5/185) | 1.99 | 0.009024 | 0.022269 |
| GO:0048640 | negative regulation of developmental growth | 0.54% (1/185) | 6.76 | 0.009195 | 0.022604 |
| GO:0006796 | phosphate-containing compound metabolic process | 8.65% (16/185) | 0.95 | 0.009517 | 0.023219 |
| GO:0045926 | negative regulation of growth | 0.54% (1/185) | 6.71 | 0.0095 | 0.023266 |
| GO:0031333 | negative regulation of protein-containing complex assembly | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:0043424 | protein histidine kinase binding | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:1902904 | negative regulation of supramolecular fiber organization | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:0032272 | negative regulation of protein polymerization | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:0051494 | negative regulation of cytoskeleton organization | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:0030837 | negative regulation of actin filament polymerization | 0.54% (1/185) | 6.67 | 0.009805 | 0.023309 |
| GO:0007005 | mitochondrion organization | 1.08% (2/185) | 3.76 | 0.009879 | 0.023399 |
| GO:0009249 | protein lipoylation | 0.54% (1/185) | 6.62 | 0.01011 | 0.023517 |
| GO:0005960 | glycine cleavage complex | 0.54% (1/185) | 6.62 | 0.01011 | 0.023517 |
| GO:0019464 | glycine decarboxylation via glycine cleavage system | 0.54% (1/185) | 6.62 | 0.01011 | 0.023517 |
| GO:0006612 | protein targeting to membrane | 1.08% (2/185) | 3.77 | 0.009684 | 0.023539 |
| GO:0006793 | phosphorus metabolic process | 8.65% (16/185) | 0.94 | 0.010015 | 0.023636 |
| GO:0051128 | regulation of cellular component organization | 1.62% (3/185) | 2.77 | 0.010053 | 0.023639 |
| GO:0006546 | glycine catabolic process | 0.54% (1/185) | 6.54 | 0.010719 | 0.024757 |
| GO:0004001 | adenosine kinase activity | 0.54% (1/185) | 6.54 | 0.010719 | 0.024757 |
| GO:0061919 | process utilizing autophagic mechanism | 1.08% (2/185) | 3.67 | 0.011084 | 0.025064 |
| GO:0006914 | autophagy | 1.08% (2/185) | 3.67 | 0.011084 | 0.025064 |
| GO:0006166 | purine ribonucleoside salvage | 0.54% (1/185) | 6.5 | 0.011024 | 0.025103 |
| GO:0043174 | nucleoside salvage | 0.54% (1/185) | 6.5 | 0.011024 | 0.025103 |
| GO:0000390 | spliceosomal complex disassembly | 0.54% (1/185) | 6.5 | 0.011024 | 0.025103 |
| GO:0032988 | protein-RNA complex disassembly | 0.54% (1/185) | 6.5 | 0.011024 | 0.025103 |
| GO:0046620 | regulation of organ growth | 0.54% (1/185) | 6.31 | 0.012545 | 0.02827 |
| GO:0070905 | serine binding | 0.54% (1/185) | 6.27 | 0.012849 | 0.028559 |
| GO:0019264 | glycine biosynthetic process from serine | 0.54% (1/185) | 6.27 | 0.012849 | 0.028559 |
| GO:0042761 | very long-chain fatty acid biosynthetic process | 0.54% (1/185) | 6.27 | 0.012849 | 0.028559 |
| GO:0004372 | glycine hydroxymethyltransferase activity | 0.54% (1/185) | 6.27 | 0.012849 | 0.028559 |
| GO:1903311 | regulation of mRNA metabolic process | 1.08% (2/185) | 3.55 | 0.012962 | 0.028712 |
| GO:0016054 | organic acid catabolic process | 1.62% (3/185) | 2.6 | 0.013801 | 0.030259 |
| GO:0046395 | carboxylic acid catabolic process | 1.62% (3/185) | 2.6 | 0.013801 | 0.030259 |
| GO:0004450 | isocitrate dehydrogenase (NADP+) activity | 0.54% (1/185) | 6.17 | 0.013761 | 0.030376 |
| GO:0006565 | L-serine catabolic process | 0.54% (1/185) | 6.02 | 0.015278 | 0.033385 |
| GO:0016758 | hexosyltransferase activity | 2.7% (5/185) | 1.79 | 0.015497 | 0.03375 |
| GO:0042455 | ribonucleoside biosynthetic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0042451 | purine nucleoside biosynthetic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0046128 | purine ribonucleoside metabolic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0009163 | nucleoside biosynthetic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0046129 | purine ribonucleoside biosynthetic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0034404 | nucleobase-containing small molecule biosynthetic process | 0.54% (1/185) | 5.97 | 0.015884 | 0.033911 |
| GO:0009927 | histidine phosphotransfer kinase activity | 0.54% (1/185) | 5.88 | 0.016793 | 0.035616 |
| GO:0009119 | ribonucleoside metabolic process | 0.54% (1/185) | 5.88 | 0.016793 | 0.035616 |
| GO:0016829 | lyase activity | 2.16% (4/185) | 2.04 | 0.017093 | 0.036134 |
| GO:0006631 | fatty acid metabolic process | 1.62% (3/185) | 2.48 | 0.017349 | 0.036557 |
| GO:0043543 | protein acylation | 1.08% (2/185) | 3.32 | 0.0175 | 0.036755 |
| GO:0046655 | folic acid metabolic process | 0.54% (1/185) | 5.81 | 0.017701 | 0.037057 |
| GO:1902936 | phosphatidylinositol bisphosphate binding | 1.08% (2/185) | 3.3 | 0.017853 | 0.037257 |
| GO:0051093 | negative regulation of developmental process | 0.54% (1/185) | 5.73 | 0.018608 | 0.038583 |
| GO:0080134 | regulation of response to stress | 1.08% (2/185) | 3.27 | 0.018673 | 0.038595 |
| GO:0022900 | electron transport chain | 1.08% (2/185) | 3.27 | 0.01857 | 0.038627 |
| GO:0051241 | negative regulation of multicellular organismal process | 0.54% (1/185) | 5.71 | 0.01891 | 0.038837 |
| GO:0019206 | nucleoside kinase activity | 0.54% (1/185) | 5.71 | 0.01891 | 0.038837 |
| GO:0050789 | regulation of biological process | 9.19% (17/185) | 0.8 | 0.019757 | 0.040449 |
| GO:0006102 | isocitrate metabolic process | 0.54% (1/185) | 5.58 | 0.020721 | 0.042024 |
| GO:0004448 | isocitrate dehydrogenase [NAD(P)+] activity | 0.54% (1/185) | 5.58 | 0.020721 | 0.042024 |
| GO:1901981 | phosphatidylinositol phosphate binding | 1.08% (2/185) | 3.19 | 0.020682 | 0.04221 |
| GO:0090150 | establishment of protein localization to membrane | 1.08% (2/185) | 3.18 | 0.021007 | 0.042473 |
| GO:1902652 | secondary alcohol metabolic process | 0.54% (1/185) | 5.5 | 0.021926 | 0.044056 |
| GO:0016836 | hydro-lyase activity | 1.08% (2/185) | 3.15 | 0.021885 | 0.044109 |
| GO:0050897 | cobalt ion binding | 0.54% (1/185) | 5.46 | 0.022529 | 0.044988 |
| GO:0030833 | regulation of actin filament polymerization | 0.54% (1/185) | 5.46 | 0.022529 | 0.044988 |
| GO:0036211 | protein modification process | 8.65% (16/185) | 0.8 | 0.022732 | 0.045254 |
| GO:1901659 | glycosyl compound biosynthetic process | 0.54% (1/185) | 5.44 | 0.022829 | 0.04531 |
| GO:0016597 | amino acid binding | 0.54% (1/185) | 5.42 | 0.02313 | 0.045767 |
| GO:0003333 | amino acid transmembrane transport | 1.08% (2/185) | 3.07 | 0.024086 | 0.047226 |
| GO:0008064 | regulation of actin polymerization or depolymerization | 0.54% (1/185) | 5.36 | 0.024032 | 0.047264 |
| GO:0030832 | regulation of actin filament length | 0.54% (1/185) | 5.36 | 0.024032 | 0.047264 |
| GO:0009966 | regulation of signal transduction | 1.08% (2/185) | 3.06 | 0.024374 | 0.047647 |
| GO:0023051 | regulation of signaling | 1.08% (2/185) | 3.05 | 0.024722 | 0.048038 |
| GO:0010646 | regulation of cell communication | 1.08% (2/185) | 3.05 | 0.024664 | 0.048069 |
| GO:0030479 | actin cortical patch | 0.54% (1/185) | 5.27 | 0.025534 | 0.04932 |
| GO:0061645 | endocytic patch | 0.54% (1/185) | 5.27 | 0.025534 | 0.04932 |
| GO:0050794 | regulation of cellular process | 8.65% (16/185) | 0.78 | 0.025644 | 0.049385 |
